807P First interim results of the radium-223 (Ra-223) REASSURE observational study: analysis of patient (Pt) characteristics and safety by use of abiraterone and/or enzalutamide (Abi/Enza).
Harshman, L Logue, John P Sternberg, C Sundar, S Schrijvers, D Schostak, M Sylvester, J George, S Tucci, M Mantz, C
Harshman, L
Logue, John P
Sternberg, C
Sundar, S
Schrijvers, D
Schostak, M
Sylvester, J
George, S
Tucci, M
Mantz, C
Citations
Altmetric:
Abstract
Description
Date
2017-09
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
807P First interim results of the radium-223 (Ra-223) REASSURE observational study: analysis of patient (Pt) characteristics and safety by use of abiraterone and/or enzalutamide (Abi/Enza). 2017, 28(suppl_5): Ann Oncol